Genprex to Present at Upcoming September Investor Conference
Corporate Presentation to Highlight Company’s Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 8, 2022 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients…
Comments Off on Genprex to Present at Upcoming September Investor Conference